In Vitro Activity of Methyl Gallate Isolated from Galla Rhois Alone and in Combination with Ciprofloxacin Against Clinical Isolates of Salmonella

被引:39
|
作者
Choi, Jang-Gi [2 ]
Kang, Ok-Hwa [2 ]
Lee, Young-Seob [2 ]
Oh, You-Chang [2 ]
Chae, Hee-Sung [2 ]
Jang, Hye-Jin [2 ]
Kim, Jong Hak [2 ]
Sohn, Dong-Hwan [1 ]
Shin, Dong-Won [3 ]
Park, Hyun [4 ]
Kwon, Dong-Yeul [1 ,2 ]
机构
[1] Wonkwang Univ, Coll Pharm, Dept Pharm, Chonbuk 570749, South Korea
[2] Wonkwang Univ, Wonkwang Oriental Med Res Inst, Chonbuk 570749, South Korea
[3] Sunchon Natl univ, Dept Oriental Med Resources, Sunchon 540742, South Korea
[4] Wonkwang Univ, Coll Med, Dept Parasitol, Chonbuk 570749, South Korea
关键词
Salmonella; ciprofloxacin; methyl gallate; synergism;
D O I
10.4014/jmb.0800.025
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Salmonella remains a primary cause of food poisoning worldwide, and massive outbreaks have been witnessed in recent years. Therefore, this study investigated the antimicrobial activity of methyl gallate (MG), which exhibited good antibacterial activity (MIC=3.9-125 mu g/ml) against all the bacterial strains tested. In a checkerboard dilution test, MG markedly lowered the MICs of ciprofloxacin (CPFX) against Salmonella. The combined activity of CPFX and MG against Salmonella resulted in fractional inhibitory concentrations (FICs) ranging from 0.0037 to 0.015 and from 0.24 to 7.8 mu g/ml, respectively. Meanwhile, the FIC index ranged from 0.31-0.37, indicating a marked synergistic relationship between CPFX and MG against Salmonella. Time-kill assays also showed a decrease in the CFU/ml between the combination and the more active compound. Therefore, this study demonstrated that MG and CPFX can act synergistically in inhibiting Salmonella in vitro.
引用
收藏
页码:1848 / 1852
页数:5
相关论文
共 50 条
  • [1] Methyl Gallate from Galla rhois Successfully Controls Clinical Isolates of Salmonella Infection in Both In Vitro and In Vivo Systems
    Choi, Jang-Gi
    Mun, Su-Hyun
    Chahar, Harendra S.
    Bharaj, Preeti
    Kang, Ok-Hwa
    Kim, Se-Gun
    Shin, Dong-Won
    Kwon, Dong-Yeul
    PLOS ONE, 2014, 9 (07):
  • [2] Antibacterial Activity of Methyl Gallate Isolated from Galla Rhois or Carvacrol Combined with Nalidixic Acid Against Nalidixic Acid Resistant Bacteria
    Choi, Jang-Gi
    Kang, Ok-Hwa
    Lee, Young-Seob
    Oh, You-Chang
    Chae, Hee-Sung
    Jang, Hye-Jin
    Shin, Dong-Won
    Kwon, Dong-Yeul
    MOLECULES, 2009, 14 (05): : 1773 - 1780
  • [3] In vitro activity of meropenem in combination with ciprofloxacin against clinical isolates of Pseudomonas aeruginosa
    Solak, S
    Willke, A
    Ergönül, Ö
    Tekeli, E
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 25 (02) : 181 - 182
  • [4] IN-VITRO ACTIVITY OF ZIDOVUDINE ALONE AND IN COMBINATION WITH CIPROFLOXACIN AGAINST SALMONELLA AND ESCHERICHIA-COLI
    MASCELLINO, MT
    IONA, E
    IEGRI, F
    DEGREGORIS, P
    FARINELLI, S
    FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 1993, 7 (01): : 23 - 28
  • [5] In-vitro activity of spiramycin and metronidazole alone or in combination against clinical isolates from odontogenic abscesses
    Roche, Y
    Yoshimori, RN
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (03) : 353 - 357
  • [6] In vitro activity of metronidazole alone and in combination with clotrimazole against clinical isolates of Trichomonas vaginalis
    Debbia, EA
    Campora, U
    Massaro, S
    Boldrini, E
    Schito, GC
    JOURNAL OF CHEMOTHERAPY, 1996, 8 (02) : 96 - 101
  • [7] In vitro activity of Tachyplesin III alone and in combination with terbinafine against clinical isolates of dermatophytes
    Simonetti, O.
    Ganzetti, G.
    Arzeni, D.
    Campanati, A.
    Marconi, B.
    Silvestri, C.
    Cirioni, O.
    Gabrielli, E.
    Lenci, I.
    Kamysz, W.
    Kamysz, E.
    Giacometti, A.
    Scalise, G.
    Barchiesi, F.
    Offidani, A.
    PEPTIDES, 2009, 30 (10) : 1794 - 1797
  • [8] In vitro antibacterial activity of enrofloxacin and ciprofloxacin in combination against Escherichia coli and staphylococcal clinical isolates from dogs
    Lautzenhiser, SJ
    Fialkowski, JP
    Bjorling, D
    Rosin, E
    RESEARCH IN VETERINARY SCIENCE, 2001, 70 (03) : 239 - 241
  • [9] In vitro activity of trovafloxacin versus ciprofloxacin against clinical isolates
    Verbist, L
    Verhaegen, J
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1996, 15 (08) : 683 - 685
  • [10] In vitro activity of ciprofloxacin, levofloxacin, and trovafloxacin, alone and in combination with β-lactams, against clinical isolates of Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Burkholderia cepacia
    Isenberg, HD
    Alperstein, P
    France, K
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1999, 33 (02) : 81 - 86